Revertant mosaicism in the skin

Giornale Italiano di Dermatologia e Venereologia

Volumn 148, Issue 1, 2013, Pages 73-82

  Lai Cheong, J E ^a   McGrath, J A ^b  

^a KING EDWARD VII HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Genetic therapy; Keratinocytes; Skin diseases, genetic

Indexed keywords

REPETITIVE DNA;

CELL THERAPY; CLINICAL FEATURE; DNA REPLICATION; DOWLING MEARA EPIDERMOLYSIS BULLOSA SIMPLEX; EPIDERMOLYSIS; EPIDERMOLYSIS BULLOSA SIMPLEX; GENE DELETION; GENE INSERTION; GENE MUTATION; GENODERMATOSIS; HUMAN; ICHTHYOSIS; ICHTHYOSIS WITH CONFETTI; MOSAICISM; NON HERLITZ JUNCTIONAL EPIDERMOLYSIS; POIKILODERMA; RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA; RECESSIVE EPIDERMOLYSIS BULLOSA SIMPLEX; REVERTANT MOSAICISM; REVIEW;

EID: 84876530135     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Jonkman MF, Pasmooij AM. Revertant mosaicism - patchwork in the skin. NEJM 2009;360:1680-2.
2. Yang TP, Stout JT, Konecki DS Patel PI, Alford RL, Caskey CT. Spontaneous reversion of novel Lesch-Nyhan mutation by HPRT gene rearrangement. Somat Cell Mol Genet 1988;14:293-303.
3. Kiritsi D, He Y, Pasmooij AM, Onder M, Happle R, Jonkmann MF et al. Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination. J Clin Invest 2012;122:1742-6.
4. Lai-Cheong JE, McGrath JA, Uitto J. Revertant mosaicism in skin: natural gene therapy. Trends Mol Med 2011;17:140-8.
5. Lai-Cheong JE, Moss C, Parsons M, Almaani N, McGrath JA. Revertant mosaicism in Kindler syndrome. J Invest Dermatol 2012;132:730-2.
6. Pasmooij AM, Jonkman MF, Uitto J. Revertant mosaicism in heritable skin diseases - mechanisms of natural gene therapy. Discov Med 2012;14:167-79.
7. Wada T, Candotti F. Somatic mosaicism in primary immune deficiencies. Curr Opin Allergy Clin Immunol 2008;8:510-4.
8. Jonkman MF, Pasmooij AM. Realm of revertant mosaicism expanding. J Invest Dermatol 2012;132:514-6.
9. Stewart DM, Candotti F, Nelson DL. The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006. J Clin Immunol 2007;27:634-9.
10. Kalb R, Neveling K, Hoehn H, Schneider H, Linka Y, Batish SD et al. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am J Hum Genet 2007;80:895-910. (Pubitemid 46668458)
11. Pasmooij AM, Nijenhuis M, Brander R, Jonkmann MF. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations. J Invest Dermatol 2012;132:1374-83.
12. Brunner HG, Jansen G, Nillesen W, Nelen MR, de Die CE, Höweler CJ et al. Brief report: reverse mutation in myotonic dystrophy. NEJM 1993;328:476-80. (Pubitemid 23056438)
13. Paller AS, Syder AJ, Chan YM, YU QC, Hutton E, Tadini G et al. Genetic and clinical mosaicism in a type of epidermal nevus. NEJM 1994;331:1408-15. (Pubitemid 24348354)
14. Pasmooij AM, Pas HH, Deviaene FC, Nijenhuis M, Jonkman MF. Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa. Am J Hum Genet 2005;77:727-40. (Pubitemid 41513276)
15. Boztug K, Germeshausen M, Avedillo Diez I, Gullacsy V, Diestelhorst J, Ballmaier M et al. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome. Clin Genet 2008;74:68-74. (Pubitemid 351833821)
16. Davis BR, Dicola MJ, Prokopishyn NL, Rosenberg JB, Moratto D, Muul LM et al. Unprecedented diversity of genotypic revenants in lymphocytes of a patient with Wiskott-Aldrich syndrome. Blood 2008;111:5064-7.
17. Du W, Kumaki S, Uchiyama T, Yachie A, Yeng Looi C, Kawai S et al. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient. Hum Mutat 2006;27:370-5.
18. Hirschhorn R. In vivo reversion to normal of inherited mutations in humans. J Med Genet 2003;40:721-8. (Pubitemid 37311069)
19. Tamai K, Yamazaki T, Chino T, Ishii M, Otsuru S, Kikuchi Y et al. PDGFRalpha-positive cells in bone marrow are mobilised by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc Natl Acad Sci USA 2011;108:6609-14.
20. Bittar M, Happle R. Revertant mosaicism and retrotransposons: another explanation of "natural gene therapy". Am J Med Genet A 2005;137:222. (Pubitemid 41262693)
21. Wada T, Schurman SH, Otsu M, Garabedian EK, Ochs HD, Nelson DL et al. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci USA 2001;98:8697-702. (Pubitemid 32678090)
22. McClintock B. Controlling elements and the gene. Cold Spring Harb Symp Quant Biol 1956;21:197-216.
23. Rakyan VK, Blewitt ME, Druker R, Preis JI, Whitelaw E. Metastable epialleles in mammals. Trends Genet 2002;18:348-51. (Pubitemid 34804446)
24. Whitelaw E, Martin DI. Retrotransposons as epigenetic mediators of phenotypic variation in mammals. Nat Genet 2001;27:361-5. (Pubitemid 32268412)
25. Viguera E, Canceill D, Ehrlich SD. Replication slippage involves DNA polymerase pausing and dissociation. EMBO J 2001;20:2587-95. (Pubitemid 32452877)
26. Viguera E, Canceill D, Ehrlich SD. In vitro replication slippage by DNA polymerases from thermophilic organisms. J Mol Biol 2001;312:323-33. (Pubitemid 32928128)
27. Levinson G, Gutman GA. Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol Biol Evol 1987;4:203-21. (Pubitemid 17116759)
28. Gache Y, Allegra M, Bodemer C, Pisani-Spadafora A, de Prost Y, Ortonne JP et al. Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging. Hum Mol Genet 2001;10:2453-61. (Pubitemid 33069551)
29. McGrath JA, Ashton GH, Mellerio JE, Salas-Alanis JC, Swensson O, McMillan JR et al. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations. J Invest Dermatol 1999;113:314-21. (Pubitemid 29449067)
30. Pasmooij AM, van Zalen S, Nijenhuis AM, Kloosterhuis J, Zuiderveen J, Jonkman MF et al. A very mild form of non-Herlitz junctional epidermolysis bullosa: BP180 rescue by outsplicing of mutated exon 30 coding for the COL15 domain. Exp Dermatol 2004;13:125-8. (Pubitemid 38247872)
31. Ruzzi L, Pas H, Posteraro P, Mazzanti C, Didona B, Owaribe K et al. A homozygous nonsense mutation in type XVII collagen gene (COL17A1) uncovers an alternatively spliced mRNA accounting for an unusually mild form of non-Herlitz junctional epidermolysis bullosa. J Invest Dermatol 2001;116:182-7. (Pubitemid 32108770)
32. Davis BR, Yan Q, Bui JH, Felix K, Moratto D, Muul LM et al. Somatic mosaicism in the Wiskott-Aldrich syndrome: molecular and functional characterization of genotypic revenants. Clin Immunol 2010;135:72-83.
33. Wada T, Yasui M, Toma T, Nakayama Y, Nishida M, Shimizu M et al. Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome. Blood 2008;112:1872-5.
34. Schuilenga-Hut PH, Scheffer H, Pas HH, Nijenhuis M, Buys CH, Jonkman MF. Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex. J Invest Dermatol 2002;118:626-30. (Pubitemid 34309981)
35. Davis BR, Candotti F. Revertant somatic mosaicism in the Wiskott-Aldrich syndrome. Immunol Res 2009;44:127-31.
36. Hamanoue S, Yagasaki H, Tsuruta T, Oda T, Yabe H, Yabe M et al. Myeloid lineage-selective growth of revertant cells in Fanconi anaemia. Br J Haematol 2006;132:630-5. (Pubitemid 43381598)
37. Choate KA, Lu Y, Zhou J, Choi M, Elias PM, Farhi A et al. Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science 2010;330:94-7.
38. Jonkman MF, Scheffer H, Stulp R, Pas HH, Nijenhuis M, Heeres K et al. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 1997;88:543-51. (Pubitemid 27154419)
39. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008;58:931-50.
40. McGrath JA, Gatalica B, Christiano AM, Li K, Owaribe K, McMillan JR et al. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet 1995;11:83-6.
41. Darling TN, Yee C, Bauer JW, Hintner H, Yancey KB. Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation. J Clin Invest 1999;103:1371-7. (Pubitemid 29535493)
42. Pasmooij AM, Pas HH, Boiling MC, Jonkman MF Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3. J Clin Invest 2007;117:1240-8. (Pubitemid 46718412)
43. Smith FJ, Morley SM, McLean WH. Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex. J Invest Dermatol 2004;122:73-7. (Pubitemid 38114641)
44. Almaani N, Liu L, Dopping-Hepenstal PJ, Lai-Cheong JE, Wong A, Nanda A et al. Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa. Acta Dermatovenereol (Stockh) 2011;91:262-6.
45. Pasmooij AM, Garcia M, Escamez MJ, Nijenhuis AM, Azon A, Cuadrado-Corrales N et al. Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2010;130:2407-11.
46. van den Akker PC, Nijenhuis M, Meijer G, Hofstra RM, Jonkman MF, Pasmooij AM. Natural gene therapy in dystrophic epidermolysis bullosa. Arch Dermatol 2012;148:213-6.
47. Kindler T. Congenital poikiloderma with traumatic bulla formation and progressive cutaneous atrophy. Br J Dermatol 1954;66:104-11.
48. Lai-Cheong JE, McGrath JA. What is Kindler syndrome? Skinmed 2011;9:145-6.
49. Lai-Cheong JE, Parsons M, Tanaka A, Ussar S, South AP, Gomathy S et al. Loss-of-function FERMT1 mutations in kindler syndrome implicate a role for fermitin family homolog-1 in integrin activation. Am J Pathol 2009;175:1431-41.
50. Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, Recchia A et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 2006;12:1397-402. (Pubitemid 44924498)
51. Baum C, Dullmann J, Li Z, Fehse B, Meyer J, Williams DA et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003;101:2099-114. (Pubitemid 36302043)
52. Cavazzana-Calvo M, Thrasher A, Mavilio F. The future of gene therapy. Nature 2004;427:779-81. (Pubitemid 38297723)
53. Nienhuis AW, Dunbar CE, Sorrentino BP. Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther 2006;13:1031-49. (Pubitemid 43779188)
54. Raya A, Rodriguez-Piza I, Navarro S, Richaud-Patin Y, Guenechea G, Sánchez-Danés A et al. A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. Nat Protoc 2010;5:647-60.
55. Tolar J, Xia L, Lees CJ, Riddle M, McElroy A, Keene DR et al. Keratinocytes from Induced Pluripotent Stem Cells in Junctional Epidermolysis Bullosa. J Invest Dermatol 2012; in press
56. Tolar J, Xia L, Riddle MJ, Lees CJ, Eide CR, McElmurry RT et al. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2011;131:848-56.
57. Itoh M, Kiuru M, Cairo MS, Christiano AM. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci USA 2011;108:8797-802.
58. Gostynski A, Deviaene FC, Pasmooij AM, Pas HH, Jonkman MF. Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy. Br J Dermatol 2009;161:444-7.
59. Yuen WY, Pasmooij AM, Stellingsma C, Jonkman MF. Enamel Defects in Carriers of a Novel LAMA3 Mutation Underlying Epidermolysis Bullosa. Acta Dermatovenereol (Stockh) 2012;92:695-6.